NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$0.08 USD
0.00 (2.34%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.08 0.00 (1.52%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum B VGM
Earnings News For NBY
-
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
-
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals Reports First Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
Analysts Estimate NovaBay Pharmaceuticals (NBY) to Report a Decline in Earnings: What to Look Out for
-
Will NovaBay Pharmaceuticals (NBY) Report Negative Earnings Next Week? What You Should Know